By Kimberly Shepard and David Vodak, Research & Development, Lonza
Lung cancer is the leading cause of cancer-related death among Americans. It is also the most common cancer worldwide, with nearly 2 million deaths per year. 90% of lung cancer cases are attributed to non-small-cell lung cancer (NSCLC). It has been reported that more than 50% of individuals with lung cancer die within one year of their diagnosis. The high mortality rate is attributed to a lack of early detection as well as a need for improved treatments.1 This article’s focus is on lung cancer treatments.